These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 11113199)

  • 1. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
    Eblen ST; Catling AD; Assanah MC; Weber MJ
    Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.
    Eblen ST; Slack JK; Weber MJ; Catling AD
    Mol Cell Biol; 2002 Sep; 22(17):6023-33. PubMed ID: 12167697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying specific kinase substrates through engineered kinases and ATP analogs.
    Kumar NV; Eblen ST; Weber MJ
    Methods; 2004 Apr; 32(4):389-97. PubMed ID: 15003601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel extracellular signal-regulated kinase docking domain inhibitors.
    Hancock CN; Macias A; Lee EK; Yu SY; Mackerell AD; Shapiro P
    J Med Chem; 2005 Jul; 48(14):4586-95. PubMed ID: 15999996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sef is a spatial regulator for Ras/MAP kinase signaling.
    Torii S; Kusakabe M; Yamamoto T; Maekawa M; Nishida E
    Dev Cell; 2004 Jul; 7(1):33-44. PubMed ID: 15239952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.
    Hong SK; Yoon S; Moelling C; Arthan D; Park JI
    J Biol Chem; 2009 Nov; 284(48):33006-18. PubMed ID: 19805545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.
    Andrade AA; Silva PN; Pereira AC; De Sousa LP; Ferreira PC; Gazzinelli RT; Kroon EG; Ropert C; Bonjardim CA
    Biochem J; 2004 Jul; 381(Pt 2):437-46. PubMed ID: 15025565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different domains of the mitogen-activated protein kinases ERK3 and ERK2 direct subcellular localization and upstream specificity in vivo.
    Robinson MJ; Xu Be BE; Stippec S; Cobb MH
    J Biol Chem; 2002 Feb; 277(7):5094-100. PubMed ID: 11741894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor.
    Hanlon M; Sturgill TW; Sealy L
    J Biol Chem; 2001 Oct; 276(42):38449-56. PubMed ID: 11500490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction.
    Vomastek T; Iwanicki MP; Burack WR; Tiwari D; Kumar D; Parsons JT; Weber MJ; Nandicoori VK
    Mol Cell Biol; 2008 Nov; 28(22):6954-66. PubMed ID: 18794356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK1/2-dependent contractile protein expression in vascular smooth muscle cells.
    Schauwienold D; Plum C; Helbing T; Voigt P; Bobbert T; Hoffmann D; Paul M; Reusch HP
    Hypertension; 2003 Mar; 41(3):546-52. PubMed ID: 12623957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.
    Dimitri CA; Dowdle W; MacKeigan JP; Blenis J; Murphy LO
    Curr Biol; 2005 Jul; 15(14):1319-24. PubMed ID: 16051177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
    Zhang J; Zhou B; Zheng CF; Zhang ZY
    J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38alpha isoform Mxi2 binds to extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase and regulates its nuclear activity by sustaining its phosphorylation levels.
    Sanz-Moreno V; Casar B; Crespo P
    Mol Cell Biol; 2003 May; 23(9):3079-90. PubMed ID: 12697810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs.
    Eblen ST; Kumar NV; Shah K; Henderson MJ; Watts CK; Shokat KM; Weber MJ
    J Biol Chem; 2003 Apr; 278(17):14926-35. PubMed ID: 12594221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides.
    Kelemen BR; Hsiao K; Goueli SA
    J Biol Chem; 2002 Mar; 277(10):8741-8. PubMed ID: 11756441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
    Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
    Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.